Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Validation that mass spectrometry can act as a diagnostic screen for patient samples from NHS test centres (i.e. validating P1 to a clinical standard); and validation of workflow to certain specifications (i.e. turnaround time).
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Liverpool University Hospitals NHS Foundation Trust | - | £19,910 | - |